The Analysis Study of Prevalence of Gastrointestinal Complication in Patients with Type 2 Diabetes Mellitus : A Comprehensive Systematic Review
Keywords:
Diabetes, gastrointestinal complications, liver, metabolicAbstract
Background: Diabetes, a chronic metabolic disorder, has a high prevalence worldwide due to changing lifestyles and urbanization. It is associated with life-threatening hazards and disabling complications, decreasing life expectancy. Gastroparesis, a well-known manifestation, is more prevalent in women. Understanding the prevalence of gastrointestinal complications in type 2 diabetes mellitus patients is crucial for creating effective treatment regimens. Methods: Adhering to the PRISMA 2020 principles, this systematic study focused on analyzing complete English literature texts published from 2011 to 2024. Several websites, such as ScienceDirect, PubMed, and SagePub, were used to collect the literature. Result: The study examined over 4000 publications sourced from recognized platforms such as Science Direct, SagePub, and PubMed. Following the decision to subject eight publications to further scrutiny, a comprehensive examination of the complete body of literature was conducted. Conclusion: Diabetes often leads to gastroparesis, a condition affecting the upper gastrointestinal tract, associated with metabolic imbalance, high blood sugar levels, low insulin, hormone release, and H. pylori infection. This condition is linked to the contractile activity of the duodenum, and is associated with various liver conditions, including diabetic fibrosis and cirrhosis.
References
Franz MJ, Warshaw H, Daly AE, Green-Pastors J, Arnold MS, Bantle J. Evolution of diabetes medical nutrition therapy. Postgrad Med J. 2003 Jan;79(927):30-5. doi: 10.1136/pmj.79.927.30. PMID: 12566549; PMCID: PMC1742592.
Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183: 109119, doi: 10.1016/j.diabres.2021.109119, indexed in Pubmed: 34879977.
International Diabetes Federation. IDF Diabetes Atlas, 10th ed., Belgium 2021. https://www.diabetesatlas.org (24.07.2023).
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.
Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15000 adults. Arch Intern Med. 2001;161:1989–96.
Du YT, Rayner CK, Jones KL, et al. Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Manage- ment. Diabetes Care. 2018; 41(3): 627–637, doi: 10.2337/dc17- 1536, indexed in Pubmed: 29463666.
Phillips LK, Rayner CK, Jones KL, Horowitz M. An update on autonomic neuropathy affecting the gastrointestinal tract. Curr Diab Rep. 2006;6(6):417–23.
Khoshbaten M, Madad L, Baladast M, et al. Gastrointestinal signs and symptoms among persons with diabetes mellitus. Gastroenterol Hepatol Bed Bench. 2011; 4(4): 219–223, indexed in Pubmed: 24834186.
Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis. Cochrane Database Syst Rev. 2007;1:CD005166.
Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;24:371–81.
Maisey, A. A Practical Approach to Gastrointestinal Complications of Diabetes. Diabetes Ther 7, 379–386 (2016). https://doi.org/10.1007/s13300-016-0182-y
Zawada, A. E., Moszak, M., Skrzypczak, D., & Grzymislawski, M. (2018). Gastrointestinal complications in patients with diabetes mellitus. In Advances in Clinical and Experimental Medicine (Vol. 27, Issue 4, pp. 567–572). Wroclaw University of Medicine. https://doi.org/10.17219/acem/67961
Kurniawan AH, Suwandi BH, Kholili U. Diabetic Gastroenteropathy: A Complication of Diabetes Mellitus. Acta Med Indones. 2019 Jul;51(3):263-271. PMID: 31699951.
Moradi Y, Baradaran HR, Djalalinia S, Chinekesh A, Khamseh ME, Dastoorpoor M, Sioofy-Khojine AB, Saed L, Qorbani M. Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis. Diabetes Metab Syndr. 2019 May-Jun;13(3):2300-2312. doi: 10.1016/j.dsx.2019.05.018. Epub 2019 May 23. PMID: 31235172.
Kazeminia M, Salari N, Shohaimi S, Akbari H, Mohammadi M. Prevalence of gastrointestinal complications in patients with type 2 diabetes mellitus in Iran: a systematic review and meta-analysis. J Diabetes Metab Disord. 2022 Jan 14;21(1):1029-1036. doi: 10.1007/s40200-022-00974-9. PMID: 35673410; PMCID: PMC9167313.
Mare, R., & Sporea, I. (2022). Gastrointestinal and Liver Complications in Patients with Diabetes Mellitus—A Review of the Literature. In Journal of Clinical Medicine (Vol. 11, Issue 17). MDPI. https://doi.org/10.3390/jcm11175223
Ud-din, M., Karout, B., Torbé, W. M., Lunding, J., Wegeberg, A. M., Drewes, A. M., Brock, C., & Hellström, P. M. (2023). DIgestive COmplications in DIabetes–the DICODI population study. In Scandinavian Journal of Gastroenterology (Vol. 58, Issue 1, pp. 3–6). Taylor and Francis Ltd. https://doi.org/10.1080/00365521.2022.2106149
Samak, M. M., Joukar, F., Maroufizadeh, S., Hassanipour, S., Ranjbar, Z. A., Yeganeh, S., Abbaspour, E., Aleali, M. S., & Mansour-Ghanaei, F. (2023). Prevalence of Gastrointestinal Symptoms among Individuals with and without Diabetes: A Cross-Sectional Study from the PERSIAN Guilan Cohort Study. Clinical Diabetology, 12(6), 370–376. https://doi.org/10.5603/cd.96670
Bharucha AE, Kudva Y, Basu A, Camilleri M, Low PA, Vella A, Zinsmeister AR. Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes. Clin Gastroenterol Hepatol. 2015 Mar;13(3):466-476.e1. doi: 10.1016/j.cgh.2014.06.034. Epub 2014 Jul 17. PMID: 25041866; PMCID: PMC4297596.
Gourcerol G, Tissier F, Melchior C, Touchais JY, Huet E, Prevost G, Leroi AM, Ducrotte P. Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation. Aliment Pharmacol Ther. 2015 Feb;41(4):360-7. doi: 10.1111/apt.13053. Epub 2014 Dec 19. PMID: 25523288.
Choi KM, Kashyap PC, Dutta N, Stoltz GJ, Ordog T, Shea Donohue T, Bauer AJ, Linden DR, Szurszewski JH, Gibbons SJ, Farrugia G. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology. 2010 Jun;138(7):2399-409, 2409.e1. doi: 10.1053/j.gastro.2010.02.014. Epub 2010 Feb 20. PMID: 20178793; PMCID: PMC2883675.
Barshop K, Staller K, Semler J, Kuo B. Duodenal rather than antral motility contractile parameters correlate with symptom severity in gastroparesis patients. Neurogastroenterol Motil. 2015 Mar;27(3):339-46. doi: 10.1111/nmo.12496. Epub 2014 Dec 17. PMID: 25521513; PMCID: PMC4432031.
He L, Sun Y, Zhu Y, Ren R, Zhang Y, Wang F. Improved gastric emptying in diabetic rats by irbesartan via decreased serum leptin and ameliorated gastric microcirculation. Genet Mol Res. 2014 Sep 5;13(3):7163-72. doi: 10.4238/2014.September.5.2. PMID: 25222222.
Pham-Short A, Donaghue KC, Ambler G, Phelan H, Twigg S, Craig ME. Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review. Pediatrics. 2015 Jul;136(1):e170-6. doi: 10.1542/peds.2014-2883. Epub 2015 Jun 15. PMID: 26077482.
Feng X, Li XQ. The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis. Aging (Albany NY). 2022 Jan 27;14(2):975-988. doi: 10.18632/aging.203854. Epub 2022 Jan 27. PMID: 35086065; PMCID: PMC8833117.
Cho YH, Ko BM, Kim SH, Myung YS, Choi JH, Han JP, Hong SJ, Jeon SR, Kim HG, Kim JO, Lee MS. Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus? Intest Res. 2014 Apr;12(2):139-45. doi: 10.5217/ir.2014.12.2.139. Epub 2014 Apr 29. PMID: 25349581; PMCID: PMC4204699.
Purchiaroni F, Galli G, Annibale B. Metformin plus proton pump inhibitors therapy: The cobalamin deficiency challenge. Eur Rev Med Pharmacol Sci. 2015;19:2501–2502.
Hudacko RM, Sciancalepore JP, Fyfe BS. Diabetic microangiopathy in the liver: an autopsy study of incidence and association with other diabetic complications. Am J Clin Pathol. 2009 Oct;132(4):494-9. doi: 10.1309/AJCPQBFF42ZZXXRQ. PMID: 19762525.
Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care. 2015 Feb;38(2):264-70. doi: 10.2337/dc14-1996. Epub 2014 Dec 8. Erratum in: Diabetes Care. 2015 Apr;38(4):734-5. doi: 10.2337/dc15-er04a. PMID: 25488912.
Vege SS, Ziring B, Jain R, Moayyedi P; Clinical Guidelines Committee; American Gastroenterology Association. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015 Apr;148(4):819-22; quize12-3. doi: 10.1053/j.gastro.2015.01.015. PMID: 25805375.
Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, Bilo HJ. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010 Feb;33(2):322-6. doi: 10.2337/dc09-1380. Epub 2009 Nov 16. PMID: 19918015; PMCID: PMC2809274.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Fahmi Fathul Rahman, Septa Istiana (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
